rc bpc 157 BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 — Evolved Science

Multi-dose use 28-day in-use period Safe for repeated needle penetration

30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)

Compared with bariatric surgery, they are non-invasive with no recovery time and nothing close to the outcome

Publications mainly in alternative medicine journals not rigorous peer-reviewed mainstream journals